Induced pluripotent stem cells from GMP-grade hematopoietic progenitor cells and mononuclear myeloid cells

INTRODUCTION: The induced pluripotent stem cell (iPSC) technology allows generation of patient-specific pluripotent stem cells, thereby providing a novel cell-therapy platform for severe degenerative diseases. One of the key issues for clinical-grade iPSC derivation is the accessibility of donor cel...

Descripción completa

Detalles Bibliográficos
Autores principales: Ohmine, Seiga, Dietz, Allan B, Deeds, Michael C, Hartjes, Katherine A, Miller, David R, Thatava, Tayaramma, Sakuma, Toshie, Kudva, Yogish C, Ikeda, Yasuhiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3340555/
https://www.ncbi.nlm.nih.gov/pubmed/22088171
http://dx.doi.org/10.1186/scrt87

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3340555/
https://www.ncbi.nlm.nih.gov/pubmed/22088171
http://dx.doi.org/10.1186/scrt87

Ejemplares similares